Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs MaxLinear Inc. Common Stock (MXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs MaxLinear Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.6 (market cap $6.04B), while MaxLinear Inc. Common Stock trades at $96.24 (market cap $8.50B). The key difference: MaxLinear Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, MaxLinear Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and MaxLinear Inc. Common Stock for 1 Days on average.
| IOVA | MXL | |
|---|---|---|
Market Cap | $6.04B | $8.50B |
Volume | 14,805,993 | 4,008,439 |
Sector | Health | Technology |
52-Week High | $14.82 | $128.03 |
52-Week Low | $1.81 | $13.05 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $8.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About MaxLinear Inc. Common Stock
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →
